La cadena de opciones muestra datos clave de las opciones de acciones de Lyell Immunopharma a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Lyell Immunopharma..

Lyell Immunopharma (NASDAQ:LYEL) Bolsa, Cadena de Opciones

LYELL IMMUNOPHARMA INC

Lyell Immunopharma

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Scotiabank analyst Greg Harrison maintains Arcturus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCT#NASDAQ">ARCT</a>) with a Sector Outperform and raises the price target from $32 to $35.

News

Price Target

Analyst Ratings

ARCT

Scotiabank Maintains Sector Outperform on Arcturus Therapeutics, Raises Price Target to $35

Keefe, Bruyette &amp; Woods analyst Wood Lay maintains Bank of Marin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRC#NASDAQ">BMRC</a>) with a Outperform and raises the price target from $26 to $27.

BMRC

Keefe, Bruyette & Woods Maintains Outperform on Bank of Marin, Raises Price Target to $27

Conagra Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) will release earnings results for the fourth quarter, before the <a href="https://www.benzinga.com/quote/CAG/earnings">opening bell on Thursday, July 10.</a>
Analysts expect the Chicago, Illinois-based company to report quarterly earnings at 61 cents per share, versus 61 cents per share in the year-ago period. Conagra Brands projects to report quarterly revenue at $2.88 billion, compared to $2.91 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On June 25, Conagra Brands announced it will complete the removal of certified food, drug, and cosmetic colors from its U.S. frozen product portfolio by the end of 2025.
Conagra Brands shares rose 2.8% to close at $21.05 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/cag/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>B of A Securities analyst Bryan Spillane downgraded the stock from Neutral to Underperform and cut the price target from $27 to $20 on June 12, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Goldman Sachs analyst Leah Jordan downgraded the stock from Neutral to Sell and slashed the price target from $26 to $21 on June 9, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Wells Fargo analyst Chris Carey maintained an Equal-Weight rating and decreased the price target from $27 to $23 on June 2, 2025. This analyst has an accuracy rate of 61%.</li>
<li>JP Morgan analyst Ken Goldman maintained a Neutral rating and cut the price target from $26 to $25 on May 6, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Morgan Stanley analyst Megan Alexander initiated coverage on the stock with an Equal-Weight rating and a price target of $27 on March 24, 2025. This analyst has an accuracy rate of 70%.</li>
</ul>
Considering buying CAG stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="586" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02002310/image-14-1024x586.png" alt="" class="wp-image-969600" style="width:598px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02002310/image-14-1024x586.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02002310/image-14-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02002310/image-14-768x439.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02002310/image-14.png 1122w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46192054/cramer-backs-this-mining-giant-after-1-6b-bet">Cramer Backs This Mining Giant After $1.6B Bet</a> </li>
</ul>
Photo via Shutterstock

Earnings

Markets

Trading Ideas

Conagra Brands Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

WIIM

CYCC

Cyclacel Pharmaceuticals share are trading lower after the company announced a 1-for-15 reverse stock split.

U.S. stocks were mixed, with the Dow Jones index falling over 100 points on Wednesday.
Shares of Hut 8 Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) rose sharply during Wednesday's session after announcing a key <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46218060/hut-8s-ontario-power-plants-secure-long-term-contracts-stock-soars">infrastructure win in Ontario.</a>
The company revealed that its joint venture, Far North Power Corp., formed alongside Macquarie Equipment Finance Ltd., a subsidiary of Macquarie Group, has secured new five-year capacity agreements for all four of its Ontario-based natural gas power plants.
Hut 8 shares jumped 15.2% to $21.28 on Wednesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Blue Gold Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGL#NASDAQ">BGL</a>) gained 56.88% to $112.84 after jumping 74% on Tuesday.</li>
<li>Namib Minerals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMM#NASDAQ">NAMM</a>) rose 45.8% to $10.02 after declining 9% on Tuesday.</li>
<li>The Greenbrier Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBX#NYSE">GBX</a>) surged 16.5% to $54.74 after the company posted stronger-than-expected results for the third quarter.</li>
<li>Ramaco Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/METC#NASDAQ">METC</a>) gained 16.2% to $11.60.</li>
<li>Prime Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) rose 15.3% to $3.1350.</li>
<li>Precigen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGEN#NASDAQ">PGEN</a>) rose 13.6% to $1.65.</li>
<li>Daqo New Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) gained 13.4% to $17.35.</li>
<li>Sionna Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SION#NASDAQ">SION</a>) rose 10.5% to $20.07.</li>
<li>Montauk Renewables, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTK#NASDAQ">MNTK</a>) gained 10.4% to $2.63.</li>
<li>Critical Metals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRML#NASDAQ">CRML</a>) rose 9.4% to $3.5760.</li>
<li>MARA Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) gained 7.1% to $16.81.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/07/46218048/how-to-earn-500-a-month-from-microsoft-stock-4">How To Earn $500 A Month From Microsoft Stock</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Movers

CRML

MARA

METC

MNTK

NAMM

PGEN

PRME

SION

Hut 8, Greenbrier And Other Big Stocks Moving Higher On Tuesday

Scotiabank analyst Orest Wowkodaw maintains Arizona Metals (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AMC#TSX">AMC</a>) with a Sector Outperform and lowers the price target from C$3.75 to C$2.5.

TSX:AMC

Scotiabank Maintains Sector Outperform on Arizona Metals, Lowers Price Target to C$2.5

CRIS

Curis shares are trading lower after the company announced a $7 million registered direct offering and concurrent private placement.

Raymond James analyst Savanthi Syth reiterates Ryanair Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYAAY#NASDAQ">RYAAY</a>) with a Strong Buy and raises the price target from $60 to $70.

Reiteration

RYAAY

Raymond James Reiterates Strong Buy on Ryanair Hldgs, Raises Price Target to $70

Legal

SNAP

Fox Business Reports Snap Issues Statement On Utah Lawsuit, Says ".. Now, Unable To Accept The Court's Rejection Of The State's Legislation, The Utah Attorney General Is Resorting To Civil Litigation..."

WINT

Windtree Therapeutics shares are trading higher after the company announced it was issued an istaroxime patent for the United States for Acute Heart Failure.

Susquehanna analyst Bascome Majors maintains Greenbrier Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBX#NYSE">GBX</a>) with a Positive and raises the price target from $52 to $57.

Susquehanna Maintains Positive on Greenbrier Companies, Raises Price Target to $57

Oppenheimer analyst Rayna Kumar maintains Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) with a Outperform and raises the price target from $390 to $391.

Oppenheimer Maintains Outperform on Visa, Raises Price Target to $391

Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) has outperformed the market over the past 15 years by 4.77% on an annualized basis producing an average annual return of 17.15%. Currently, Seagate Tech Hldgs has a market capitalization of $31.14 billion. 
Buying $1000 In STX: If an investor had bought $1000 of STX stock 15 years ago, it would be worth $10,928.68 today based on a price of $147.10 for STX at the time of writing.
<h3>Seagate Tech Hldgs's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751465748_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Seagate Tech Hldgs 15 Years Ago Would Be Worth Today

A budget-conscious Reddit user in the <a href="https://www.reddit.com/r/Frugal/comments/1ljp9nh/instacart_vs_in_person_shopping_cost_analysis/">r/Frugal</a> subreddit recently shared a side-by-side cost analysis of buying groceries through Instacart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) versus shopping in person. It sparked a wide-ranging conversation about convenience, cost, and tipping culture that many like-minded shoppers chimed in on.
<h2 class="wp-block-heading">Paying For Convenience Adds Up Quickly</h2>
The original poster said they were feeling lazy and nearly <a href="https://www.benzinga.com/25/02/43671734/instacart-has-extensive-retailer-integrations-and-high-quality-shopping-experience-says-analyst">placed an Instacart order</a>. But curiosity kicked in. &#8220;I cancelled the order and went to the store (Wegmans) to buy the exact items,&#8221; they wrote. The result? The Instacart version would have cost $15.46 more for the same groceries.
Don't Miss:
<ul class="wp-block-list">
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
</ul>
That difference came from several sources: the fee, the delivery fee, the tip, and the per-item price increase, which also raises the tax. While some dismissed that increase as the cost of convenience, many commenters thought the markup was too steep.&nbsp; &#8220;Instacart marks up the prices majorly in my area. I&#8217;ve never even considered ordering from them,&#8221; one person wrote.
Others echoed similar concerns. One commenter said they stopped using Instacart after noticing that the substitutions and item quality weren't consistent with what they would choose themselves.
<h2 class="wp-block-heading">Disability, Illness And Transportation Make A Difference</h2>
Many Redditors said they rely on grocery delivery due to health issues, lack of a car, or extreme weather. &#8220;I&#8217;m disabled, and it can be really difficult to go grocery shopping sometimes,&#8221; one wrote. &#8220;It&#8217;s legitimately been so helpful while I try and get my health issues under control.&#8221;
Trending: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a>
Another said: &#8220;I do pet sitting but don&#8217;t own a car&#8230; Given that my apartment and job both charge for parking—combined about $2.2K a year—I&#8217;ve calculated I&#8217;m coming out ahead getting my groceries delivered.&#8221;
There was also a practical angle: <a href="https://www.benzinga.com/personal-finance/25/05/45494677/ramit-sethi-reveals-3-quick-wins-to-save-100-without-giving-up-everything-you-love-you-dont-have-to-sit-at-home-with-the-lights-off">avoiding impulse spending</a>. &#8220;When I use a delivery service&#8230; I stick to my list and I can comparison shop better,&#8221; one user wrote. &#8220;Even though I pay a convenience fee for grocery delivery, my total spending has not increased.&#8221;
<h2 class="wp-block-heading">Tipping Sparked Heated Reactions</h2>
OP mentioned tipping $3 on the Instacart order, which many readers saw as too low: &#8220;If you're going to use a convenience service, you absolutely need to tip more.&#8221;
Several gig workers commented directly. &#8220;I obsess over picking good produce and make about $35 an hour,&#8221; one Instacart shopper wrote. Another added: &#8220;IC pay starts at $4 per order&#8230; We deal with lines, finding obscure products, our gas, time, and effort.&#8221;
However, as this is the frugal community, one person also wondered, &#8220;Do you tip the normal checkout person?&#8221;
See Also: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
<h2 class="wp-block-heading">Curbside Pickup: The Budget-Friendly Middle Ground?</h2>
One solution kept popping up: curbside pickup. It avoids delivery fees and tipping, but still saves time. As someone said, &#8220;It&#8217;s the best of both worlds.&#8221;&nbsp;
Some retailers like Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) and Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) offer in-store prices for pickup, with people reporting they <a href="https://www.benzinga.com/money/how-to-create-a-budget">stick to their budgets</a> better and avoid buying unnecessary extras.&nbsp;
And although Instacart and other delivery services can easily add 10% to 30% to your grocery bill. But for many, it's a worthwhile tradeoff.
Read Next: Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Now Raising at $3/Share</a>
Image: Shutterstock

Personal Finance

CART

A Frugal Shopper Did A Cost Analysis Of Instacart Vs. In-Store Shopping. Here's How The Expenses Compare

Oppenheimer analyst Rayna Kumar maintains Sezzle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEZL#NASDAQ">SEZL</a>) with a Outperform and raises the price target from $168 to $202.

SEZL

Oppenheimer Maintains Outperform on Sezzle, Raises Price Target to $202

Oppenheimer analyst Owen Lau maintains S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) with a Outperform and raises the price target from $567 to $592.

SPGI

Oppenheimer Maintains Outperform on S&P Global, Raises Price Target to $592

JP Morgan Chase &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) shares are trending on Wednesday. Here&#8217;s a look at <a href="https://www.benzinga.com/news/financing/25/07/46213890/wall-streets-100-billion-payout-parade-jpmorgan-morgan-stanley-goldman-lead-capital-return-wave-after-acing-feds-2025-stress-test">what&#8217;s going on</a>.
What To Know: JPMorgan shares traded higher in after-hours Tuesday after the company announced a dividend increase and authorized a new buyback.
The company&#8217;s board announced that it intends to increase the quarterly stock dividend from $1.40 per share to $1.50 per share for the third quarter. 
JPMorgan&#8217;s board also announced a share repurchase program of $50 billion, effective as of Tuesday. 
&#8220;The Board's intended dividend increase, our second this year, represents a sustainable level of capital distribution to our shareholders and is supported by our strong financial performance. The new share repurchase program provides the ability to distribute capital to our shareholders over time, as we see fit,&#8221; said Jamie Dimon, chairman and CEO of JPMorgan. 
&#8220;Our fortress balance sheet, with significant excess capital and robust liquidity, enables us to be a pillar of strength — in both good times and bad times — allowing us to consistently serve our clients, communities, and countries throughout the world.&#8221;
The news comes after JPMorgan completed its stress test. The Federal Reserve lowered the bank&#8217;s Stress Capital Buffer requirement from 3.3% to 2.5% and its Standardized Common Equity Tier 1 capital ratio requirement from 12.3% to 11.5%. The new requirements are set to become effective on Oct. 1. 
JPM Price Action: <a href="http://benzinga.com/quote/JPM">JPMorgan shares</a> traded up to around $293 in after-hours trading Tuesday before pulling back. The stock was down 0.11% at $290.12 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46214540/palmer-luckey-peter-thiel-joe-lonsdale-launch-erebor-bank-for-startups-crypto-and-defense-a-digital-only-bet-on-the-post-svb-era-report">Palmer Luckey, Peter Thiel, Joe Lonsdale Launch Erebor Bank For Startups, Crypto And Defense — A Digital-Only Bet On The Post-SVB Era: Report</a></li>
</ul>
Photo: Shutterstock.

Buybacks

Federal Reserve

JPMorgan Stock Is Trending Wednesday: What's Happening?

<a href="https://x.com/CitronResearch/status/1940412266853380103" title="https://x.com/CitronResearch/status/1940412266853380103">https://x.com/CitronResearch/status/1940412266853380103</a>

Watching Rocket Companies; Shares See Volume To The Upside, Citron Research Posts About Co On X

RIVN

Rivian Automotive shares are trading lower after the compnoay provided Q2 production and delivery numbers.

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 50 points on Wednesday.
Following the market opening Wednesday, the Dow traded down 0.22% to 44,398.83 while the NASDAQ gained 0.25% to 20,252.83. The S&amp;P 500 also fell, dropping, 0.02% to 6,196.53.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/dividends/25/07/46218048/how-to-earn-500-a-month-from-microsoft-stock-4">How To Earn $500 A Month From Microsoft Stock</a>
Leading and Lagging Sectors Materials shares jumped by 0.5% on Wednesday.
In trading on Wednesday, health care stocks fell by 0.6%.
Top Headline
Shares of UniFirst Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNF#NYSE">UNF</a>) fell over 2% after the company reported mixed results for the third quarter on Wednesday.
The company posted quarterly earnings of $2.17 per share which beat the analyst consensus estimate of $2.09 per share. The company reported quarterly sales of $610.778 million which missed the analyst consensus estimate of $614.510 million.
UniFirst raised its FY2025 GAAP earnings guidance from $7.30-$7.70 per share to $7.60-$8.00 per share.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>CID HoldCo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAIC#NASDAQ">DAIC</a>) shares shot up 154% to $11.73.</li>
<li>Shares of Mogo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOGO#NASDAQ">MOGO</a>) got a boost, surging 138% to $2.8748 after the company announced a $50 million bitcoin treasury authorization.</li>
<li>Blue Gold Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGL#NASDAQ">BGL</a>) shares were also up, gaining 63% to $117.27.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>BioNexus Gene Lab Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) shares dropped 47% to $5.90.</li>
<li>Shares of Mustang Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) were down 41% to $1.2106 after jumping 115% on Tuesday.</li>
<li>Centene Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) was down, falling 37% to $35.99 after the company withdrew its previous 2025 GAAP and adjusted diluted EPS guidance, including the underlying guidance elements.</li>
</ul>
Commodities In commodity news, oil traded up 0.5% to $65.75 while gold traded down 0.1% at $3,347.00.
Silver traded up 0.2% to $36.475 on Wednesday, while copper rose 1.3% to $5.1645.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 fell 0.2%, while Spain's IBEX 35 Index rose 0.1%. London's FTSE 100 fell 0.5%, Germany's DAX 40 gained 0.1% and France's CAC 40 gained 0.9% during the session.
Asia Pacific Markets
Asian markets closed lower on Wednesday, with Japan's Nikkei dipping 0.56%, China's Shanghai Composite falling 0.09% and India's BSE Sensex falling 0.34%.
Economics
<ul class="wp-block-list">
<li>U.S.-based employers announced job cuts of 47,999 in June versus 93,816 in the previous month and 48,786 in the year-ago period.</li>
<li>The volume of mortgage applications increased by 2.7% from the previous week during the last week of June.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46192054/cramer-backs-this-mining-giant-after-1-6b-bet">Cramer Backs This Mining Giant After $1.6B Bet</a> </li>
</ul>
Photo via Shutterstock

Equities

Eurozone

Commodities

BGLC

DAIC

MBIO

MOGO

US Stocks Mixed; UniFirst Shares Fall After Q3 Results

Health Care

Press Releases

General

Lyell to Highlight Vision for its Next-Generation CAR T-Cell Therapy Pipeline at 43rd Annual JP Morgan Healthcare Conference

Lyell Immunopharma Announces Participation in Upcoming Investor Conferences

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024

Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma

Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2025

Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference

Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive Appointments

Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma

Comments

Lyell Immunopharma

Lyell Immunopharma (LYEL) Opciones

Lyell Immunopharma (NASDAQ:LYEL) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL